Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.49 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.46 |
| ▸ | TOP1 | P11387 | 4/20 | 0.44 |
| ▸ | CYCS | P99999 | 3/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MPI | P34949 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29888944 | 1.00 | TERT (0.49) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL30679527 | 0.86 | TERT (0.48) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL22473799 | 0.85 | TOP1 (0.54) | ABCG2TOP1CYCSENPP2KMT2A | |
| SCHEMBL29441514 | 0.84 | ABCG2 (0.49) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL30616085 | 0.84 | ABCG2 (0.49) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL499168 | 0.84 | ABCG2 (0.49) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL2950389 | 0.83 | STAT3 (0.54) | TERTABCG2KDM4EALDH1A1GAA | |
| SCHEMBL498495 | 0.81 | TERT (0.51) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL29408468 | 0.81 | TERT (0.51) | TERTABCG2TOP1CYCSENPP2 | |
| SCHEMBL2694939 | 0.81 | NOX1 (0.49) | TERTABCG2TOP1CYCSENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9867800-B2 | Method of quenching singlet and triplet excited states of pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds have electron withdrawing groups, to reduce generation of reactive oxygen species, particularly singlet oxygen | HALLSTAR INNOVATIONS CORP. (US) | 2018-01-16 | — | — | US | claimed |
| US-20150164852-A1 | METHOD OF QUENCHING SINGLET AND TRIPLET EXCITED STATES OF PIGMENTS, SUCH AS PORPHYRIN COMPOUNDS, PARTICULARLY PROTOPORPHYRIN IX, WITH CONJUGATED FUSED TRICYCLIC COMPOUNDS HAVE ELECTRON WITHDRAWING GROUPS, TO REDUCE GENERATION OF REACTIVE OXYGEN SPECIES, PARTICULARLY SINGLET OXYGEN | HALLSTAR INNOVATIONS CORP. (US) | 2015-06-18 | — | — | US | claimed |
| WO-2014025370-A1 | TRICYCLIC ENERGY QUENCHER COMPOUNDS FOR REDUCING SINGLET OXYGEN GENERATION | HALLSTAR INNOVATIONS CORP. (US) | 2014-02-13 | — | — | WO | claimed |
| US-6010805-A | Ion conducting electrolyte material containing a lithium porphyrin complex | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2000-01-04 | — | — | US | claimed |
| US-12546743-B2 | Electrochemical sensor and related methods | UNIVERSITY OF SOUTH FLORIDA (US) | 2026-02-10 | — | — | US | disclosed |
| US-12071498-B2 | Radically polymerizable compositions | Polynt Composites USA, Inc. (US) | 2024-08-27 | — | — | US | disclosed |
| CN-113474383-B | Free radical polymerizable composition | 波林复合材料美国股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| US-20230296554-A1 | ELECTROCHEMICAL SENSOR AND RELATED METHODS | UNIVERSITY OF SOUTH FLORIDA | 2023-09-21 | — | — | US | disclosed |
| US-20230257500-A1 | RADICALLY POLYMERIZABLE COMPOSITIONS | BNY MELLON CORPORATE TRUSTEE SERVICES LIMITED, AS SECURITY AGENT (GB) | 2023-08-17 | — | — | US | disclosed |
| US-11518834-B2 | Radically polymerizable compositions | Polynt Composites USA, Inc. (US) | 2022-12-06 | — | — | US | disclosed |
| EP-3077467-B1 | DRIER COMPOSITION AND USE THEREOF | PPG EUROPE B V (NL) | 2022-11-02 | — | — | EP | disclosed |
| EP-3906265-A1 | RADICALLY POLYMERIZABLE COMPOSITIONS | Polynt Composites USA Inc. (US) | 2021-11-10 | — | — | EP | disclosed |
| EP-1545512-A1 | METHODS FOR USING GOLD (III) COMPLEXES AS ANTI-TUMOR AND ANTI-HIV AGENTS | The University of Hong Kong (CN) | 2005-06-29 | — | — | EP | disclosed |
| US-20040266748-A1 | Photosensitizing carbamate derivatives | MIRAVANT PHARMACEUTICALS, INC. | 2004-12-30 | — | — | US | disclosed |
| EP-1450790-A2 | PHOTOSENSITIZING CARBAMATE DERIVATIVES | Miravant Pharmaceuticals, Inc. (US) | 2004-09-01 | — | — | EP | disclosed |
| US-20040063681-A1 | Methods for using gold (III) complexes as anti-tumor and anti-HIV agents | CHE CHI-MING (CN) | 2004-04-01 | — | — | US | disclosed |
| WO-2004024146-A1 | METHODS FOR USING GOLD (III) COMPLEXES AS ANTI-TUMOR AND ANTI-HIV AGENTS | THE UNIVERSITY OF HONG KONG (CN) | 2004-03-25 | — | — | WO | disclosed |
| US-6609014-B1 | Use of PDT to inhibit intimal hyperplasia | QLT INC. (CA) | 2003-08-19 | — | — | US | disclosed |
| WO-2003028628-A2 | PHOTOSENSITIZING CARBAMATE DERIVATIVES | MIRAVANT PHARMACEUTICALS, INC. (US) | 2003-04-10 | — | — | WO | disclosed |
| US-6010805-A | Ion conducting electrolyte material containing a lithium porphyrin complex | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 2000-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063681-A1 | Methods for using gold (III) complexes as anti-tumor and anti-HIV agents | HCCS, ME3, IDH1 | TERT 1918/4885ABCG2 820/4885TOP1 71/4885 |
| US-12546743-B2 | Electrochemical sensor and related methods | EPX, MUC1, EPCAM | TERT 3462/4885ABCG2 4259/4885TOP1 4862/4885 |
| US-20150164852-A1 | METHOD OF QUENCHING SINGLET AND TRIPLET EXCITED STATES OF PIGMENTS, SUCH AS PORPHYRIN COMPOUNDS, PARTICULARLY PROTOPORPHYRIN IX, WITH CONJUGATED FUSED TRICYCLIC COMPOUNDS HAVE ELECTRON WITHDRAWING GROUPS, TO REDUCE GENERATION OF REACTIVE OXYGEN SPECIES, PARTICULARLY SINGLET OXYGEN | NOX3, CBR3, CCR3 | TERT 1768/4885ABCG2 2540/4885TOP1 1886/4885 |
| US-20040266748-A1 | Photosensitizing carbamate derivatives | CRY1, CASP3, CRY2 | TERT 1623/4885ABCG2 1974/4885TOP1 1039/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.